Nature GeneticsGeneticsPeer-reviewed journal article
Mapping interindividual dynamics of innate immune response at single-cell resolution
Natsuhiko KumasakaiD, Raghd RostomiD, Ni HuangiD, Krzysztof PolańskiiD, Kerstin B. MeyeriD, Sharad R. PateliD, Rachel Boyd, Céline Gomez, Sam N. BarnettiD, Nikolaos I. PanousisiD, Jeremy SchwartzentruberiD, Maya GhoussainiiD, Paul LyonsiD, Fernando J. Calero‐NietoiD, Berthold GöttgensiD, Josephine L. BarnesiD, Kaylee B. WorlockiD, Masahiro YoshidaiD, Marko NikolićiD, Emily StephensoniD, Gary ReynoldsiD, Muzlifah A. HaniffaiD, John C. MarioniiD, Oliver StegleiD, Tzachi HagaiiD, Sarah Amalia TeichmanniD
Abstract
Common genetic variants modulate the cellular response to viruses and are implicated in a range of immune pathologies, including infectious and autoimmune diseases. The transcriptional antiviral response is known to vary between infected cells from a single individual, yet how genetic variants across individuals modulate the antiviral response (and its cell-to-cell variability) is not well understood. Here, we triggered the antiviral response in human fibroblasts from 68 healthy donors, and profiled tens of thousands of cells using single-cell RNA-seq. We developed GASPACHO (GAuSsian Processes for Association mapping leveraging Cell HeterOgeneity), the first statistical approach designed to identify dynamic eQTLs across a transcriptional trajectory of cell populations, without aggregating single-cell data into pseudo-bulk. This allows us to uncover the underlying architecture and variability of antiviral response across responding cells, and to identify more than two thousands eQTLs modulating the dynamic changes during this response. Many of these eQTLs colocalise with risk loci identified in GWAS of infectious and autoimmune diseases. As a case study, we focus on a COVID-19 susceptibility locus, colocalised with the antiviral OAS1 splicing QTL. We validated it in blood cells from a patient cohort and in the infected nasal cells of a patient with the risk allele, demonstrating the utility of GASPACHO to fine-map and functionally characterise a genetic locus. In summary, our novel analytical approach provides a new framework for delineation of the genetic variants that shape a wide spectrum of transcriptional responses at single-cell resolution.
- organism: human
- assay: scRNA-seq
- research focus: eQTL / molecular QTL mapping
- research focus: fine-mapping
- research focus: gene regulatory network inference
- research focus: differential expression
- approach: statistical model
- Citations
- 46
- FWCI
- 7.13
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell RNA-sequencing reveals pervasive but highly cell type-specific genetic ancestry effects on the response to viral infection
Haley E. Randolph, Zepeng Mu, … Luis Bruno Barreiro·bioRxiv·Dec 21, 2020
- Single-cell eQTL mapping identifies disease-specific genetic control of COVID-19 infection
Jennifer Astley, Andrew John Kwok, … Luke Jostins-Dean·medRxiv·Jun 30, 2025
- Widespread gene-environment interactions shape the immune response to SARS-CoV-2 infection in hospitalized COVID-19 patients
Haley E. Randolph, Raúl Aguirre‐Gamboa, … Luis Bruno Barreiro·Nature CommunicationsPeer-reviewed·Apr 28, 2026
- Lung expression of genes encoding SARS-CoV-2 cell entry molecules and antiviral restriction factors: interindividual differences are associated with age and germline variants
Chiara Elisabetta Cotroneo, Nunzia Mangano, … Francesca Colombo·European Journal of Human GeneticsPeer-reviewed·Mar 1, 2021
- The landscape of host genetic factors involved in immune response to common viral infections
Linda Kachuri, Stephen Starko Francis, … John S. Witte·Genome MedicinePeer-reviewed·Oct 27, 2020
- Environmental and genetic drivers of population differences in SARS-CoV-2 immune responses
Yann Aquino, Aurélie Bisiaux, … Lluís Quintana‐Murci·bioRxiv·Nov 22, 2022